{"entity":{"type":"insider","cik":"0001760460","url":"/insider/0001760460","json_url":"/insider/0001760460.json","name":"Puissance Life Science Opportunities Fund VI","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":5,"first":"2018-12-03","last":"2023-10-16","span_basis":"filed_date"},"name_variants":[{"name":"Puissance Life Science Opportunities Fund VI","source":"filing","n_filings":5,"first_seen":"2018-12-03","last_seen":"2023-10-16"}],"transactions":[{"id":8345589,"accession":"0001760460-23-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001760460-23-000008","line_url":"/filing/0001760460-23-000008#line-1","is_derivative":false,"issuer_cik":"0001600132","issuer_name":"Bellerophon Therapeutics, Inc.","issuer_ticker":"BLPH","issuer_name_source":null,"issuer_url":"/issuer/0001600132","owner_cik":null,"owner_name":"Puissance Capital Fund (GP) LLC; Wang Theodore T; Puissance Life Science Opportunities Fund VI; Puissance Capital Management LP","owner_display_name":"Puissance Capital Fund (GP) LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1076841.0,"shares_display":"1,076,841","price_per_share":0.1038,"price_display":"0.10","price_state":"stated","total_value":111776.0958,"total_display":"111,776.10","total_whole":"111,776","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-13","filed_date":"2023-10-16","scope":"insider"},{"id":8270588,"accession":"0001760460-23-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001760460-23-000006","line_url":"/filing/0001760460-23-000006#line-1","is_derivative":false,"issuer_cik":"0001600132","issuer_name":"Bellerophon Therapeutics, Inc.","issuer_ticker":"BLPH","issuer_name_source":null,"issuer_url":"/issuer/0001600132","owner_cik":null,"owner_name":"Puissance Life Science Opportunities Fund VI; Puissance Capital Management LP; Puissance Capital Fund (GP) LLC; Wang Theodore T","owner_display_name":"Puissance Life Science Opportunities Fund VI","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":134421.0,"shares_display":"134,421","price_per_share":0.83,"price_display":"0.83","price_state":"stated","total_value":111569.43,"total_display":"111,569.43","total_whole":"111,569","shares_owned_after":1076841.0,"shares_owned_after_display":"1,076,841","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-07","filed_date":"2023-06-07","scope":"insider"},{"id":7852202,"accession":"0001760460-23-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001760460-23-000003","line_url":"/filing/0001760460-23-000003#line-1","is_derivative":false,"issuer_cik":"0001600132","issuer_name":"Bellerophon Therapeutics, Inc.","issuer_ticker":"BLPH","issuer_name_source":null,"issuer_url":"/issuer/0001600132","owner_cik":null,"owner_name":"Puissance Capital Management LP; Puissance Life Science Opportunities Fund VI; Wang Theodore T; Puissance Capital Fund (GP) LLC","owner_display_name":"Puissance Capital Management LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":560000.0,"shares_display":"560,000","price_per_share":9.46,"price_display":"9.46","price_state":"stated","total_value":5297600.0,"total_display":"5,297,600.00","total_whole":"5,297,600","shares_owned_after":1211262.0,"shares_owned_after_display":"1,211,262","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-18","filed_date":"2023-05-19","scope":"insider"},{"id":9295547,"accession":"0001733439-18-000016","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001733439-18-000016","line_url":"/filing/0001733439-18-000016#line-2","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":null,"owner_name":"Puissance Capital Fund (GP) LLC; Puissance Capital Management (GP) LLC; Puissance Capital Management LP; Puissance Cross-Border Opportunities IV LLC; Puissance Cross-Border Opportunities V LLC; Puissance Life Science Opportunities Fund VI; Wang Theodore T","owner_display_name":"Puissance Capital Fund (GP) LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4326.0,"shares_display":"4,326","price_per_share":1.21,"price_display":"1.21","price_state":"stated","total_value":5234.46,"total_display":"5,234.46","total_whole":"5,234","shares_owned_after":4601768.0,"shares_owned_after_display":"4,601,768","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-11-29","filed_date":"2018-12-03","scope":"insider"},{"id":9295546,"accession":"0001733439-18-000016","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001733439-18-000016","line_url":"/filing/0001733439-18-000016#line-1","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":null,"owner_name":"Puissance Capital Fund (GP) LLC; Puissance Capital Management (GP) LLC; Puissance Capital Management LP; Puissance Cross-Border Opportunities IV LLC; Puissance Cross-Border Opportunities V LLC; Puissance Life Science Opportunities Fund VI; Wang Theodore T","owner_display_name":"Puissance Capital Fund (GP) LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4326.0,"shares_display":"4,326","price_per_share":1.13,"price_display":"1.13","price_state":"stated","total_value":4888.38,"total_display":"4,888.38","total_whole":"4,888","shares_owned_after":4606094.0,"shares_owned_after_display":"4,606,094","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-11-29","filed_date":"2018-12-03","scope":"insider"},{"id":6172026,"accession":"0001733439-18-000015","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001733439-18-000015","line_url":"/filing/0001733439-18-000015#line-2","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":null,"owner_name":"Puissance Capital Management LP; Puissance Life Science Opportunities Fund VI; Wang Theodore T; Puissance Cross-Border Opportunities IV LLC; Puissance Capital Management (GP) LLC; Puissance Cross-Border Opportunities V LLC; Puissance Capital Fund (GP) LLC","owner_display_name":"Puissance Capital Management LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4326.0,"shares_display":"4,326","price_per_share":1.21,"price_display":"1.21","price_state":"stated","total_value":5234.46,"total_display":"5,234.46","total_whole":"5,234","shares_owned_after":4601768.0,"shares_owned_after_display":"4,601,768","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-11-29","filed_date":"2018-12-03","scope":"insider"},{"id":6172015,"accession":"0001733439-18-000015","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001733439-18-000015","line_url":"/filing/0001733439-18-000015#line-1","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":null,"owner_name":"Puissance Capital Management LP; Puissance Life Science Opportunities Fund VI; Wang Theodore T; Puissance Cross-Border Opportunities IV LLC; Puissance Capital Management (GP) LLC; Puissance Cross-Border Opportunities V LLC; Puissance Capital Fund (GP) LLC","owner_display_name":"Puissance Capital Management LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4326.0,"shares_display":"4,326","price_per_share":1.13,"price_display":"1.13","price_state":"stated","total_value":4888.38,"total_display":"4,888.38","total_whole":"4,888","shares_owned_after":4606094.0,"shares_owned_after_display":"4,606,094","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-11-29","filed_date":"2018-12-03","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001600132","name":"Bellerophon Therapeutics, Inc.","url":"/issuer/0001600132","role":"Ten percent owner","n_filings":3,"first_seen":"2023-05-19","last_seen":"2023-10-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001394319","name":"Tracon Pharmaceuticals, Inc.","url":"/issuer/0001394319","role":"Ten percent owner","n_filings":2,"first_seen":"2018-12-03","last_seen":"2018-12-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001760460","retrieved_at":"2026-08-22T04:54:46+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}